首页> Expert review of clinical pharmacology> Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

导出原文传递

翻译打印收藏纠错

第一作者： McBride, Ali

作者： McBride, Ali ^[1] ; Bonafede, Machaon ^[2] ; Cai, Qian ^[3] ; Princic, Nicole ; Tran, Oth ; Pelletier, Corey ; Parisi, Monika ; Patel, Manish

作者单位： Celgene Corp, Summit, NJ USA ^[1] Truven Hlth Analyt, Ann Arbor, MI USA ^[2] Univ Arizona, Canc Ctr, Phoenix, AZ USA ^[3]

关键词 Economic burden FOLFIRINOX gemcitabine plus nanoparticle albumin-bound paclitaxel metastatic pancreatic cancer real-world data treatment patterns

发布时间 2019-09-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert review of clinical pharmacology

2017年10卷7/12期

1153-1160页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Expert review of clinical pharmacology

2017年10卷7/12期

1153-1160页

检索历史清除

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

Expert review of clinical pharmacology

相似文献

同项目论文

Expert review of clinical pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

Expert review of clinical pharmacology

相似文献

同项目论文

Expert review of clinical pharmacology

相关期刊

检索历史清除